# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-035989
Filing Date
2023-11-01
Accepted
2023-11-01 16:17:10
Documents
84
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmo-20230930.htm iXBRL | 10-Q | 1258865
2 | EX-10.1 | sangamoexecutiveseveranc.htm | EX-10.1 | 80443
3 | EX-31.1 | sgmo-20230930xex311.htm | EX-31.1 | 10022
4 | EX-31.2 | sgmo-20230930xex312.htm | EX-31.2 | 10137
5 | EX-32.1 | sgmo-20230930xex321.htm | EX-32.1 | 7140
11 | GRAPHIC | sangamoexecutiveseveranc001.jpg | GRAPHIC | 218326
12 | GRAPHIC | sangamoexecutiveseveranc002.jpg | GRAPHIC | 239095
13 | GRAPHIC | sangamoexecutiveseveranc003.jpg | GRAPHIC | 259689
14 | GRAPHIC | sangamoexecutiveseveranc004.jpg | GRAPHIC | 269737
15 | GRAPHIC | sangamoexecutiveseveranc005.jpg | GRAPHIC | 299447
16 | GRAPHIC | sangamoexecutiveseveranc006.jpg | GRAPHIC | 259254
17 | GRAPHIC | sangamoexecutiveseveranc007.jpg | GRAPHIC | 271332
18 | GRAPHIC | sangamoexecutiveseveranc008.jpg | GRAPHIC | 288687
19 | GRAPHIC | sangamoexecutiveseveranc009.jpg | GRAPHIC | 245005
20 | GRAPHIC | sangamoexecutiveseveranc010.jpg | GRAPHIC | 209163
21 | GRAPHIC | sangamoexecutiveseveranc011.jpg | GRAPHIC | 243093
22 | GRAPHIC | sangamoexecutiveseveranc012.jpg | GRAPHIC | 307747
23 | GRAPHIC | sangamoexecutiveseveranc013.jpg | GRAPHIC | 172438
24 | GRAPHIC | sangamoexecutiveseveranc014.jpg | GRAPHIC | 276587
25 | GRAPHIC | sangamoexecutiveseveranc015.jpg | GRAPHIC | 298977
26 | GRAPHIC | sangamoexecutiveseveranc016.jpg | GRAPHIC | 232043
27 | GRAPHIC | sangamoexecutiveseveranc017.jpg | GRAPHIC | 300986
28 | GRAPHIC | sangamoexecutiveseveranc018.jpg | GRAPHIC | 280279
29 | GRAPHIC | sangamoexecutiveseveranc019.jpg | GRAPHIC | 296155
30 | GRAPHIC | sangamoexecutiveseveranc020.jpg | GRAPHIC | 268265
31 | GRAPHIC | sangamoexecutiveseveranc021.jpg | GRAPHIC | 257772
32 | GRAPHIC | sangamoexecutiveseveranc022.jpg | GRAPHIC | 180884
33 | GRAPHIC | sangamoexecutiveseveranc023.jpg | GRAPHIC | 41239
| Complete submission text file | 0001628280-23-035989.txt |  | 14180890

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20230930.xsd | EX-101.SCH | 45833
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sgmo-20230930_cal.xml | EX-101.CAL | 60259
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20230930_def.xml | EX-101.DEF | 255807
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20230930_lab.xml | EX-101.LAB | 499885
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20230930_pre.xml | EX-101.PRE | 337203
78 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20230930_htm.xml | XML | 929142

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 231368484
SIC: 2836 Biological Products, (No Diagnostic Substances)